Some evidence show that GCB-DLBCL cells are sensitive to SYK inhibition and that SYK blockage decreases BCR/PI3K/AKT activity, decreases the proliferation and induces apoptosis [53,54]. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.